Development of integrated membrane bioreactor and numerical modeling to mitigate fouling and reduced energy consumption in pharmaceutical wastewater treatment

Mechanisms and Strategies of Advanced Oxidation Processes for Membrane Fouling Control in MBRs: Membrane-Foulant Removal versus Mixed-Liquor Improvement

Membrane bioreactors (MBRs) are well-established and widely utilized technologies with substantial large-scale plants around the world for municipal and industrial wastewater treatment. Despite their widespread adoption, membrane fouling presents a significant impediment to the broader application of MBRs, necessitating ongoing research and development of effective antifouling strategies. As highly promising, efficient, and environmentally friendly chemical methods for water and wastewater treatment, advanced oxidation processes (AOPs) have demonstrated exceptional competence in the degradation of pollutants and inactivation of bacteria in aqueous environments, exhibiting considerable potential in controlling membrane fouling in MBRs through direct membrane foulant removal (MFR) and indirect mixed-liquor improvement (MLI). Recent proliferation of research on AOPs-based antifouling technologies has catalyzed revolutionary advancements in traditional antifouling methods in MBRs, shedding new light on antifouling mechanisms. To keep pace with the rapid evolution of MBRs, there is an urgent need for a comprehensive summary and discussion of the antifouling advances of AOPs in MBRs, particularly with a focus on understanding the realizing pathways of MFR and MLI. In this critical review, we emphasize the superiority and feasibility of implementing AOPs-based antifouling technologies in MBRs. Moreover, we systematically overview antifouling mechanisms and strategies, such as membrane modification and cleaning for MFR, as well as pretreatment and in-situ treatment for MLI, based on specific AOPs including electrochemical oxidation, photocatalysis, Fenton, and ozonation. Furthermore, we provide recommendations for selecting antifouling strategies (MFR or MLI) in MBRs, along with proposed regulatory measures for specific AOPs-based technologies according to the operational conditions and energy consumption of MBRs. Finally, we highlight future research prospects rooted in the existing application challenges of AOPs in MBRs, including low antifouling efficiency, elevated additional costs, production of metal sludge, and potential damage to polymeric membranes. The fundamental insights presented in this review aim to elevate research interest and ignite innovative thinking regarding the design, improvement, and deployment of AOPs-based antifouling approaches in MBRs, thereby advancing the extensive utilization of membrane-separation technology in the field of wastewater treatment.

Effects of pharmaceuticals on membrane bioreactor: Review on membrane fouling mechanisms and fouling control strategies

Pharmaceuticals have become contaminants of emerging concern due to their toxicity towards aquatic life and pseudo persistent nature in the environment. Membrane bioreactor (MBR) is one such technology that has the potential to act as a barrier against the release of pharmaceuticals into the environment. Fouling is the deposition of the constituents of the mixed liquor on the membrane surface and it limit the world-wide applicability of MBRs. To remove foulant layer, aggressive chemicals and extra cost consideration in terms of energy are required. Extracellular polymeric substances (EPS) and soluble microbial products (SMP) are recognized as principal foulants. Presence of pharmaceuticals has been found to increase the fouling in MBRs. Fouling aggravates in proportion to the concentration of pharmaceuticals. Pharmaceuticals exert chemical stress in microbes, hence forcing them to secrete more EPS/SMP. Pharmaceuticals alter the composition of the foulants and affect microbial metabolism, thereby inflicting direct/indirect effects on fouling. Pharmaceuticals have been found to increase or decrease the size of sludge flocs, however the exact mechanism that govern the floc size change is yet to be understood. Different techniques such as coupling advanced oxidation processes with MBR, adding activated carbon, bioaugmenting MBR with quorum quenching strains have shown to reduce fouling in MBRs treating pharmaceutical wastewater. These fouling mitigation techniques work on reducing the EPS/SMP concentration, thereby alleviating fouling. The present review provides a comprehensive understanding of the effects induced by pharmaceuticals in the activated sludge characteristics and identifying the fouling mechanism. Furthermore, significant knowledge gaps and recent advances in fouling mitigation strategies are discussed. This review has also made an effort to highlight the positive aspect of the foulant layer in retaining pharmaceuticals and antibiotic resistance genes, thereby suggesting a possible delicate trade-off between the flux decline and enhanced removal of pharmaceuticals.

Adsorption and detoxification of pharmaceutical compounds from wastewater using nanomaterials: A review on mechanism, kinetics, valorization and circular economy

Antibiotics overuse, inappropriate conduct, and discharge have led to adverse effects on various ecosystems. The occurrence of antibiotics in surface and drinking water is a matter of global concern. It is responsible for multiple disorders, including disruption of endocrine hormones and high chronic toxicity. The hospitals, pharmaceutical industries, households, cattle farms, and aquaculture are the primary discharging sources of antibiotics into the environment. This review provides complete detail on applying different nanomaterials or nanoparticles for the efficient removal of antibiotics from the diverse ecosystem with a broader perspective. Efforts have been made to focus on the degradation pathways and mechanism of antibiotic degradation using nanomaterials. More light has been shed on applying nanostructures in photocatalysis, which would be an economical and efficient solution. The nanoscale material or nanoparticles have incredible potential for mineralizing pharmaceutical compounds in aqueous solutions at low cost, easy handling characteristics, and high efficacy. Furthermore, nanoparticles can absorb the pharmaceutical by-products and wastes at a minimum cost as they can be easily recycled. With the increasing number of research in this direction, the valorization of pharmaceutical wastes and by-products will continue to expand as we progress from old conventional approaches towards nanotechnology. The utilization of nanomaterials in pharmaceutical wastewater remediation is discussed with a major focus on valorization, energy generation, and minimization and its role in the circular economy creating sustainable development.